Firm seeks NIH grant to conduct study of epilepsy Dx tool

04/30/2013 | MedCityNews.com

A pair of doctors who founded Cognizance Biomarkers are working on a blood-based test to detect epilepsy more precisely and reduce overdiagnosis of the condition. The firm is applying for NIH funding to conduct a proof of principle study for the assay, which is intended to locate an anti-inflammatory protein originating from the brain that is often found in low concentrations in epilepsy patients.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL